7 Crucial Cost & Drivers of D&O Insurance
Head of Claims
Head of Claims
It’s not breaking news that the media features more lawsuits involving directors and officers of various companies. Many experts believe this trend has only begun, that we’ll see more of these “headliners” in the days to come. With the COVID-19 crisis not yet in our rearview mirror, companies must face a shifting directors and officers (D&O) insurance market. In this post, we’ve rounded up factors that impact the cost of D&O insurance and why it matters to you.
The short answer is yes, no doubt. However, understanding this phenomenon requires a deeper dive into industry dynamics. First, let’s examine why D&O lawsuits happen in the first place. Whether a company is private or public, executives and board of directors members guide companies to success. As a result, they experience a growing amount of crossfire and for plenty of reasons, including:
Additionally, it’s not merely social inflation that’s impacting D&O trends. Attorney and Executive VP at RT ProExec, Kevin LaCroix, predicted an uptick in D&O claims due to the COVID-19 outbreak. What’s more, he explains, “Though the number of coronavirus-related securities suits so far is relatively modest, a number of patterns have emerged.” These patterns mean companies might experience a rise in premium rates, as well.
On top of that, companies pay lawyers a minimum average of $35,000 to $100,000 to defend each incident. Plus, indemnity payments average around $500,000 but can quickly skyrocket to seven figures or higher. Lamentably, D&O claims are increasing in cost as well as frequency.
The following are a few crucial factors that impact D&O insurance costs — and some of the most vital for company leaders to know.
What sector of the market does your company serve? This element might influence your D&O insurance cost more than you know. For example, the investment banking and securities industry frequently expose company leaders to many risks, more than other sectors.
Additionally, the life sciences industry faces mounds of unique risks, including those relating to royalties, licensing agreements, venture capital (VC) investor backing, etc. Insurers are well aware of these vulnerabilities and will often respond by increasing the cost of D&O insurance.
Younger companies tend to have less experience and a shorter time frame, proving their risk management plan’s effectiveness. Even though some board of director members might have plenty of experience under their belts, underwriters often view younger companies as “fresh faces.” Moreover, they’ll view newer businesses as riskier to insure than well-developed companies, for example.
Typically, older and more developed businesses have experienced directors and officers, and thus, pose less risk than the newbies, per se. That said, your company’s development stage plays a significant role in what drives the cost of D&O insurance.
As mentioned, life sciences companies can burn through VC funding faster than a wildfire, mostly early in the clinical trials process. It’s the nature of the business, and insurers acknowledge this distinct fact. Debt is also another underwriting consideration not to go unmentioned.
Part of D&O coverage offers corporate indemnification. This portion protects directors and officers, so their personal assets aren’t at stake. Though unstable finances could change a company’s risk level, making insolvency a genuine threat in a lawsuit.
As you may have guessed, your company’s legal history could keep you from landing the best D&O insurance premiums. Previous lawsuits and shifts in leadership impact D&O insurance rates significantly.
An excellent approach is being forthcoming with questionable business developments clouding your past — because underwriters will uncover them anyway. But even underwriters possess some level of understanding, analyzing your litigation history with a merciless fine-toothed comb in one hand and a dose of empathy in the other.
No matter if your company has undergone an initial public offering (IPO) or not, your directors and officers still face plenty of risks. However, the exposures undoubtedly increase for public company leaders. A lot rides on directors and officers during and after an IPO. The company might not meet expectations, disappointing loads of shareholders. In short, leaders are at the helm of their company, which makes them more vulnerable than mere employees.
Employment-related claims are one of the leading causes of D&O lawsuits. And this trend shows no signs of slowing down anytime soon. The more significant your employee pool, the more chance your directors and officers will come under fire with legal issues.
Data analysis is vital to ensure you’ve got enough D&O coverage to protect your business from employment-related lawsuits. Some companies buy too much insurance, while others don’t purchase enough. For this reason, it’s best to analyze your employment-related risks intricately (or hire someone to investigate them for you).
Lastly, do your services or products cross the big blue, per se? If so, this aspect of international involvement can quickly complicate the D&O underwriting process. Your company must comply with domestic laws as well as regulations in other countries. Naturally, these factors add a few layers of complexity to your D&O insurance needs.
While every company has unique needs, it’s best to familiarize yourself with your D&O insurance policy. Tailor your coverage based on your specific risks. For example, know your limits of liability and be aware of any exclusions. This approach will help you formulate an adequate D&O policy that will protect what needs protecting. Keep in mind that D&O coverage features three parts, including:
Side A: Suppose directors are personally sued and are forced to pay defense costs and settlements, this portion of D&O insurance kicks in to protect the individual. However, Side A will only pay the individual directors if the entity can’t, such as if the company is insolvent. Many pre-IPO companies opt for additional Side A coverage limits, which is an excellent option.
Side B: When the company (or entity) indemnifies individuals named in the lawsuit, Side B coverage reimburses those costs. But it only extends to indemnifying insured individuals named in the lawsuit.
Side C: This coverage provides a balance sheet protection for the company named in a lawsuit alongside an individual director. Side C coverage will reimburse the costs and settlements incurred.
Understanding the details of what coverage your company needs can be a confusing process. Founder Shield specializes in knowing the risks your industry faces to make sure you have adequate protection. Feel free to reach out to us, and we’ll walk you through the process of finding the right policy for you.
If you’re interested in learning more about a customized D&O insurance program, please reach a member of our team by phone at 646-956-5140 or email at email@example.com or create an account here to get started on a quote.
Special purpose acquisition companies (SPACs) are growing in popularity — but they also face new exposures. Here’s how to manage SPAC risks.
Several tech companies have gone public simultaneously. After reviewing each, here are some lessons we can learn from the IPO rush.
VC funding for life sciences companies has evolved significantly in the past two decades. Here’s what you need to know about financing in the space.